Digital health company Better Therapeutics has submitted its lead prescription digital therapeutic (DTx) BT-001 to the FDA, seeking approval for use by adults with type 2 diabetes (T2D).

DTX Exchange is revolutionizing the crypto industry with its dual-chain system that merges centralized and decentralized operations. The project is riding on momentum as it hits $14 million in ...

DTX Exchange, a leading asset trading platform, has confirmed its final presale token price at $0.36 as it enters the closing phase of its token sale. DTX Exchange has raised over $15.1 million ...